153 related articles for article (PubMed ID: 16571278)
1. Clinical study of Jiawei Huangqi Guizhi Wuwu Decoction in preventing and treating peripheral neuro-sensory toxicity caused by oxaliplatin.
Li Y; Cui HJ; Huang JC; Wu XQ
Chin J Integr Med; 2006 Mar; 12(1):19-23. PubMed ID: 16571278
[TBL] [Abstract][Full Text] [Related]
2. Study on efficacy and safety of Huangqi Guizhi Wuwu decoction treatment for oxaliplatin induced peripheral neurotoxicity: A protocol for a randomized, controlled, double-blind, multicenter trial.
Wei XM; Chen XF; Shu P; Jiang ZW; Wu XY; Zou X; Chen K; Shen B; Hu WW; Lu W; Shen WX; Li L; Wang JY; Zhao FJ; Yin QF; Cheng HB; Gu YH
Medicine (Baltimore); 2020 May; 99(22):e19923. PubMed ID: 32481364
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Huangqi Guizhi Wuwu Decoction for Oxaliplatin-Induced Peripheral Neurotoxicity: A Systematic Review and Meta-Analysis.
Yu J; Chen S; Wei G; Gu J; Huo J; Ding R; Li L
Altern Ther Health Med; 2024 Jan; 30(1):446-453. PubMed ID: 37820675
[TBL] [Abstract][Full Text] [Related]
4. Huangqi Guizhi Wuwu Decoction can prevent and treat oxaliplatin-induced neuropathic pain by TNFα/IL-1β/IL-6/MAPK/NF-kB pathway.
Li M; Li Z; Ma X; Jin S; Cao Y; Wang X; Zhao J; Wang J; Wang X; Xu J
Aging (Albany NY); 2022 Jun; 14(12):5013-5022. PubMed ID: 35759577
[TBL] [Abstract][Full Text] [Related]
5. Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy.
Durand JP; Alexandre J; Guillevin L; Goldwasser F
Anticancer Drugs; 2005 Jun; 16(5):587-91. PubMed ID: 15846125
[TBL] [Abstract][Full Text] [Related]
6. Huangqi Guizhi Wuwu decoction in peripheral neurotoxicity treatment using network pharmacology and molecular docking.
Chen T; Shi Y; Shi W
Medicine (Baltimore); 2022 Oct; 101(42):e31281. PubMed ID: 36281162
[TBL] [Abstract][Full Text] [Related]
7. Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet-NEUROXAPOL: protocol of a prospective, randomised, controlled, single-blind and monocentric trial.
Balayssac D; Ferrier J; Pereira B; Gillet B; Pétorin C; Vein J; Libert F; Eschalier A; Pezet D
BMJ Open; 2015 Apr; 5(4):e007479. PubMed ID: 25833669
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of Huangqi Guizhi Wuwu decoction for rheumatoid arthritis: A protocol for systematic review and meta-analysis.
Wang L; Fan Y; Xin P; Zhao Y; Deng H; Jia B
Medicine (Baltimore); 2020 Sep; 99(36):e22011. PubMed ID: 32899051
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin-safety profile: neurotoxicity.
Grothey A
Semin Oncol; 2003 Aug; 30(4 Suppl 15):5-13. PubMed ID: 14523789
[TBL] [Abstract][Full Text] [Related]
10. [Basic evidence for efficacy of Goshajinkigan on oxaliplatin-induced neuropathy].
Ushio S; Kawashiri T; Egashira N
Nihon Yakurigaku Zasshi; 2014 Mar; 143(3):126-30. PubMed ID: 24614635
[No Abstract] [Full Text] [Related]
11. An overview of chemotherapy-induced peripheral sensory neuropathy, focusing on oxaliplatin.
Gent P; Massey K
Int J Palliat Nurs; 2001 Jul; 7(7):354-9. PubMed ID: 11951404
[TBL] [Abstract][Full Text] [Related]
12. Laser acupuncture attenuates oxaliplatin-induced peripheral neuropathy in patients with gastrointestinal cancer: a pilot prospective cohort study.
Hsieh YL; Chou LW; Hong SF; Chang FC; Tseng SW; Huang CC; Yang CH; Yang CC; Chiu WF
Acupunct Med; 2016 Oct; 34(5):398-405. PubMed ID: 27613370
[TBL] [Abstract][Full Text] [Related]
13. Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer.
Argyriou AA; Cavaletti G; Briani C; Velasco R; Bruna J; Campagnolo M; Alberti P; Bergamo F; Cortinovis D; Cazzaniga M; Santos C; Papadimitriou K; Kalofonos HP
Cancer; 2013 Jan; 119(2):438-44. PubMed ID: 22786764
[TBL] [Abstract][Full Text] [Related]
14. Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents.
Ushio S; Egashira N; Sada H; Kawashiri T; Shirahama M; Masuguchi K; Oishi R
Eur J Cancer; 2012 Jun; 48(9):1407-13. PubMed ID: 21907570
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of oxaliplatin-induced neuropathy by carbamazepine. A pilot study].
Eckel F; Schmelz R; Adelsberger H; Erdmann J; Quasthoff S; Lersch C
Dtsch Med Wochenschr; 2002 Jan; 127(3):78-82. PubMed ID: 11797144
[TBL] [Abstract][Full Text] [Related]
16. [Promising effects of pregabalin in the treatment of oxaliplatin-induced sensory neuropathy in patients with colorectal carcinoma].
Nagahara H; Noda E; Maeda K; Inoue T; Hirakawa T; Hasegawa T; Shibutani M; Hirakawa K
Gan To Kagaku Ryoho; 2013 Sep; 40(9):1181-3. PubMed ID: 24047775
[TBL] [Abstract][Full Text] [Related]
17. Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx
Glimelius B; Manojlovic N; Pfeiffer P; Mosidze B; Kurteva G; Karlberg M; Mahalingam D; Buhl Jensen P; Kowalski J; Bengtson M; Nittve M; Näsström J
Acta Oncol; 2018 Mar; 57(3):393-402. PubMed ID: 29140155
[TBL] [Abstract][Full Text] [Related]
18. Acute oxaliplatin-induced peripheral nerve hyperexcitability.
Wilson RH; Lehky T; Thomas RR; Quinn MG; Floeter MK; Grem JL
J Clin Oncol; 2002 Apr; 20(7):1767-74. PubMed ID: 11919233
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of calcium and magnesium infusions in the chemoprevention of oxaliplatin-induced sensory neuropathy in gastrointestinal cancers.
Xu XT; Dai ZH; Xu Q; Qiao YQ; Gu Y; Nie F; Zhu MM; Tong JL; Ran ZH
J Dig Dis; 2013 Jun; 14(6):288-98. PubMed ID: 23432969
[TBL] [Abstract][Full Text] [Related]
20. Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study.
Oki E; Emi Y; Kojima H; Higashijima J; Kato T; Miyake Y; Kon M; Ogata Y; Takahashi K; Ishida H; Saeki H; Sakaguchi Y; Yamanaka T; Kono T; Tomita N; Baba H; Shirabe K; Kakeji Y; Maehara Y
Int J Clin Oncol; 2015 Aug; 20(4):767-75. PubMed ID: 25627820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
